Literature DB >> 34875123

Pseudoreticulocytosis in a patient with myelodysplastic syndrome.

Noemy De Rossi1, Lorenzo Alberio1, Grégoire Stalder1.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34875123      PMCID: PMC9306652          DOI: 10.1002/ajh.26431

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   13.265


× No keyword cloud information.
A 52‐year‐old woman diagnosed in 2017 with low‐risk myelodysplastic syndrome (MDS) with multilineage dysplasia (R‐IPSS score 1.5) is evaluated for persistent reticulocytosis since 4 years, without evidence of bleeding or hemolysis. Her laboratory results indicate the following: red blood count 3.56 × 1012/L (reference range: 3.8–5.2 × 1012/L); hemoglobin 10.1 g/dL (11.7–15.7 g/dL); hematocrit 0.32 L/L (0.35–0.47 L/L); MCV 93 fl (81–99 fl); MCHC 313 g/L (310–360 g/L); red cell distribution width 16.7% (11%–15%); reticulocytes 929 × 109/L (20–120 × 109/L), 26.1% (0.5%–1.5%); platelets 146 × 109/L (150–350 × 109/L); and leukocytes 2.2 × 109/L (4.0–10 × 109/L). Of note, MCV, expected to be increased in case of reticulocytosis is normal. Hemolytic parameters (LDH, bilirubin, haptoglobin) and creatinine are normal. The direct antiglobulin test is negative. Scattergram (Image 1A, white circle) shows small‐size reticulocytes with dim fluorescence (low RNA content), corresponding to a population of old reticulocytes. Peripheral blood smear (Image 1B) shows marked anisopoikilocytosis, polychromasia, and anisochromia. Presence of reticulocytes is confirmed on cresyl blue stain (Image 1C, arrows).
IMAGE 1

Morphologic and flow cytometry features of old reticulocytes. (A), Scattergram (Sysmex XN9000) (FSC, forward‐scattered light; SFL, side‐fluorescence light) demonstrating a population of low‐size reticulocytes with dim fluorescence (white circle). (B), Peripheral blood smear showing anisopoikilocytosis, polychromasia, and anisochromia (hematoxylin and eosin stain, original magnification ×1000). (C), Peripheral blood smear with arrows showing reticulocytes with dim fluorescence (low RNA content) on cresyl blue stain (original magnification ×1000)

Morphologic and flow cytometry features of old reticulocytes. (A), Scattergram (Sysmex XN9000) (FSC, forward‐scattered light; SFL, side‐fluorescence light) demonstrating a population of low‐size reticulocytes with dim fluorescence (white circle). (B), Peripheral blood smear showing anisopoikilocytosis, polychromasia, and anisochromia (hematoxylin and eosin stain, original magnification ×1000). (C), Peripheral blood smear with arrows showing reticulocytes with dim fluorescence (low RNA content) on cresyl blue stain (original magnification ×1000) The phenomenon of increased reticulocytes without hemolysis or bleeding among patients with MDS has been described in few publications. , It is a consequence of abnormal erythropoiesis with underlying delayed reticulocyte maturation, which may arise because of altered ribonucleic acid metabolism or a deficiency of ribonuclease. This process results in an increased number of circulating older reticulocytes with smaller size and low RNA content. Under normal conditions, reticulocytes have a half‐life of 24–48 h in the peripheral circulation, before losing their RNA and becoming erythrocytes. Due to delayed maturation, reticulocytes retain their RNA for a longer time, resulting in a prolonged half‐life in peripheral blood and thus in “pseudoreticulocytosis.”

CONFLICT OF INTEREST

All authors declare that they have no conflict of interest.
  4 in total

Review 1.  Reticulocytes and reticulocyte enumeration.

Authors:  R S Riley; J M Ben-Ezra; R Goel; A Tidwell
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  Pseudoreticulocytosis in a case of myelodysplastic syndrome.

Authors:  G Carulli; A Marini; A Azzarà; A Lucchetti; M Petrini
Journal:  Acta Haematol       Date:  1998-12       Impact factor: 2.195

3.  Pseudoreticulocytosis in a patient with myelodysplasia.

Authors:  B Hertenstein; E Kurrle; M Redenbacher; R Arnold; H Heimpel
Journal:  Ann Hematol       Date:  1993-09       Impact factor: 3.673

4.  Pseudoreticulocytosis in a patient with myelodysplastic syndrome.

Authors:  Noemy De Rossi; Lorenzo Alberio; Grégoire Stalder
Journal:  Am J Hematol       Date:  2021-12-21       Impact factor: 13.265

  4 in total
  1 in total

1.  Pseudoreticulocytosis in a patient with myelodysplastic syndrome.

Authors:  Noemy De Rossi; Lorenzo Alberio; Grégoire Stalder
Journal:  Am J Hematol       Date:  2021-12-21       Impact factor: 13.265

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.